An Wang

5PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 12, 2026
Grade 3 and above opportunistic pneumonia or drug-induced interstitial lung disease during tyrosine-kinase inhibitor treatment for advanced non-small-cell lung cancer with RET fusion mutations: coexistence of risks and opportunities.

An Wang, Tao Li, Yun-Ye Mao

|Jul 28, 2025
Systematic pan-cancer analysis identified NCOA4 as an immunological and prognostic biomarker and validated in lung adenocarcinoma.

An Wang, Yun-Ye Mao, Tao Li

|Jul 23, 2025
PD-1/PD-L1 inhibitors monotherapy vs. combination therapy in elderly advanced NSCLC: a real-world study and nomogram for survival prognosis.

Yunye Mao, An Wang, Xiangwei Ge

|Apr 24, 2025
A comprehensive analysis of deubiquitinase USP20 on prognosis and immunity in pan-cancer.

Ting Wang, Yibing Bai, Yi Dong

|Nov 04, 2024
Evolution of treatment strategies for solid tumors with RET rearrangement in China and real-world treatment status of Non-small Cell Lung Cancer (NSCLC).

An Wang, Tao Li, Yun-Ye Mao

Pageof 1

Frequent Collaborators

5 joint publications

Yi Hu

3 joint publications

Tao Li

3 joint publications

Yunye Mao

1 joint publications

Ting Wang